The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Sven-Ove Ögren sits on this spectrum.
This scientist: 386 publications — 90th percentile
90% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Sven-Ove Ögren sits on this spectrum.
This scientist: 80 D-Index — 83rd percentile
83% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Sven-Ove Ögren mainly investigates Internal medicine, Endocrinology, Dopamine, Pharmacology and Dopamine receptor D2. His Internal medicine study frequently links to other fields, such as Neuroscience. His Endocrinology study incorporates themes from Neuropeptide and Monoamine neurotransmitter, Serotonin.
His work in the fields of Dopamine, such as Dopaminergic, Dopamine receptor, Dopamine receptor D1 and Raclopride, intersects with other areas such as Offspring. The concepts of his Dopaminergic study are interwoven with issues in Neurturin, GDNF family of ligands and Anatomy. The various areas that Sven-Ove Ögren examines in his Pharmacology study include Striatum, Receptor, Postsynaptic potential, Zimelidine and Antidepressant.
Sven-Ove Ögren mostly deals with Endocrinology, Internal medicine, Pharmacology, Neuroscience and Dopamine. The Endocrinology study combines topics in areas such as Agonist, Neuropeptide, Receptor, Galanin and Serotonin. His Receptor study combines topics in areas such as Cerebral cortex and Binding site.
Sven-Ove Ögren focuses mostly in the field of Internal medicine, narrowing it down to matters related to Desipramine and, in some cases, Neurotoxin. His research in Pharmacology focuses on subjects like Antidepressant, which are connected to Mechanism of action. His Dopamine receptor D2 research integrates issues from Dopaminergic and Catalepsy.
His primary areas of study are Internal medicine, Endocrinology, Pharmacology, Neuroscience and Galanin. His study in the field of Muscarinic acetylcholine receptor, Microdialysis, 5-HT receptor and Agonist also crosses realms of Behavioural analysis. His research integrates issues of AMPA receptor and Neuroprotection in his study of Endocrinology.
The study incorporates disciplines such as Dopamine receptor D2, Dopamine, Male mice and Antagonism in addition to Pharmacology. His work investigates the relationship between Dopamine receptor D2 and topics such as Dopaminergic that intersect with problems in Tyrosine hydroxylase. He interconnects Hippocampus, Acetylcholine and Cholinergic in the investigation of issues within Galanin.
Sven-Ove Ögren focuses on Pharmacology, Endocrinology, Internal medicine, Dopamine and Neuroscience. His Pharmacology research is multidisciplinary, relying on both Male mice, Dopamine β hydroxylase, Anxiolytic and Zimelidine. His Endocrinology research is multidisciplinary, incorporating perspectives in Agonist and Galanin, Galanin receptor 2.
His research investigates the connection between Galanin and topics such as Microdialysis that intersect with issues in Acetylcholine and 5-HT receptor. His research in the fields of Dopaminergic and Dopamine receptor D2 overlaps with other disciplines such as Chlorphentermine. His studies deal with areas such as Antidepressant, 5-HT2A receptor, 5-HT6 receptor and Serotonergic as well as Dopamine receptor D2.
A. Tomac;E. Lindqvist;L.-F. H. Lin;S. O. Ögren
Christer Köhler;Håkan Hall;Sven-Ove Ögren;Lars Gawell
Sven Ove Ögren;Therese M. Eriksson;Elin Elvander-Tottie;Claudio D’Addario
Johan Sandin;Jeanette Georgieva;Pär A. Schött;Sven O. Ögren
S O Ogren;H Hall;C Köhler;O Magnusson
S.O. Ögren;H. Hall;C. Köhler;O. Magnusson
S. O. Ögren;K. Fuxe;L. F. Agnati;Jan-Ake Gustafsson
Börje Bjelke;Kurt Andersson;Sven Ove Ögren;Per Bolme
A. Kuzmin;J. Sandin;L. Terenius;S. O. Ögren
Ilga Misane;Philip Tovote;Michael Meyer;Joachim Spiess
K. Fuxe;S.-O. Ögren;L.F. Agnati;F. Benfenati
Erling Ehrin;Lars Farde;Tomas de Paulis;Lars Eriksson
Roberto Rimondini;Sergi Ferré;Sven Ove Ögren;Kjell Fuxe
Mark J. Millan;Guy M. Goodwin;Andreas Meyer-Lindenberg;Sven Ove Ögren
Fuxe K;Farnebo Lo;Hamberger B;Ogren So
Henrich Cheng;Henrich Cheng;Susanne Almström;Lydia Giménez-Llort;Robert Chang
Ogren So;Kehr J;Schött Pa
Sven Ove Ögren;Menek Goldstein
S.O. Ögren;T. Hökfelt;K. Kask;Ü. Langel
G. Chadi;A. Mø er;L. Rosen;A. M. Janson
Sergi Ferré;William T. O'Connor;Per Svenningsson;Lars Björklund
If you think any of the details on this page are incorrect, let us know.
Delft University of Technology
University of Michigan–Ann Arbor
The University of Texas at Austin
Centre de Coopération Internationale en Recherche Agronomique pour le Développement
University of Antwerp
Norwegian University of Science and Technology
Broad Institute
French Geological Survey
Utrecht University
Harbin Institute of Technology
Nagoya University
Beijing University of Chemical Technology
University of Amsterdam
Texas A&M University
National Oceanic and Atmospheric Administration
Macquarie University
